229 related articles for article (PubMed ID: 38242992)
1. NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting.
Sharma S; Ehrlich M; Zhang M; Blobe GC; Henis YI
Commun Biol; 2024 Jan; 7(1):112. PubMed ID: 38242992
[TBL] [Abstract][Full Text] [Related]
2. VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation.
Herzog B; Pellet-Many C; Britton G; Hartzoulakis B; Zachary IC
Mol Biol Cell; 2011 Aug; 22(15):2766-76. PubMed ID: 21653826
[TBL] [Abstract][Full Text] [Related]
3. VEGF (Vascular Endothelial Growth Factor) Induces NRP1 (Neuropilin-1) Cleavage via ADAMs (a Disintegrin and Metalloproteinase) 9 and 10 to Generate Novel Carboxy-Terminal NRP1 Fragments That Regulate Angiogenic Signaling.
Mehta V; Fields L; Evans IM; Yamaji M; Pellet-Many C; Jones T; Mahmoud M; Zachary I
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1845-1858. PubMed ID: 29880492
[TBL] [Abstract][Full Text] [Related]
4. VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival.
Morin E; Sjöberg E; Tjomsland V; Testini C; Lindskog C; Franklin O; Sund M; Öhlund D; Kiflemariam S; Sjöblom T; Claesson-Welsh L
J Pathol; 2018 Nov; 246(3):311-322. PubMed ID: 30027561
[TBL] [Abstract][Full Text] [Related]
5. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting.
Pan Q; Chathery Y; Wu Y; Rathore N; Tong RK; Peale F; Bagri A; Tessier-Lavigne M; Koch AW; Watts RJ
J Biol Chem; 2007 Aug; 282(33):24049-56. PubMed ID: 17575273
[TBL] [Abstract][Full Text] [Related]
6. Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling.
Tual-Chalot S; Garcia-Collado M; Redgrave RE; Singh E; Davison B; Park C; Lin H; Luli S; Jin Y; Wang Y; Lawrie A; Jakobsson L; Arthur HM
Circ Res; 2020 Jan; 126(2):243-257. PubMed ID: 31805812
[TBL] [Abstract][Full Text] [Related]
7. Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells.
Raimondi C; Fantin A; Lampropoulou A; Denti L; Chikh A; Ruhrberg C
J Exp Med; 2014 Jun; 211(6):1167-83. PubMed ID: 24863063
[TBL] [Abstract][Full Text] [Related]
8. Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization.
Kawamura H; Li X; Goishi K; van Meeteren LA; Jakobsson L; Cébe-Suarez S; Shimizu A; Edholm D; Ballmer-Hofer K; Kjellén L; Klagsbrun M; Claesson-Welsh L
Blood; 2008 Nov; 112(9):3638-49. PubMed ID: 18664627
[TBL] [Abstract][Full Text] [Related]
9. Neuropilin-1 signaling through p130Cas tyrosine phosphorylation is essential for growth factor-dependent migration of glioma and endothelial cells.
Evans IM; Yamaji M; Britton G; Pellet-Many C; Lockie C; Zachary IC; Frankel P
Mol Cell Biol; 2011 Mar; 31(6):1174-85. PubMed ID: 21245381
[TBL] [Abstract][Full Text] [Related]
10. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
11. Raftlin is recruited by neuropilin-1 to the activated VEGFR2 complex to control proangiogenic signaling.
Bayliss AL; Sundararaman A; Granet C; Mellor H
Angiogenesis; 2020 Aug; 23(3):371-383. PubMed ID: 32274611
[TBL] [Abstract][Full Text] [Related]
12. NRP1 presented in trans to the endothelium arrests VEGFR2 endocytosis, preventing angiogenic signaling and tumor initiation.
Koch S; van Meeteren LA; Morin E; Testini C; Weström S; Björkelund H; Le Jan S; Adler J; Berger P; Claesson-Welsh L
Dev Cell; 2014 Mar; 28(6):633-46. PubMed ID: 24656741
[TBL] [Abstract][Full Text] [Related]
13. Alphav beta3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesis.
Robinson SD; Reynolds LE; Kostourou V; Reynolds AR; da Silva RG; Tavora B; Baker M; Marshall JF; Hodivala-Dilke KM
J Biol Chem; 2009 Dec; 284(49):33966-81. PubMed ID: 19837659
[TBL] [Abstract][Full Text] [Related]
14. Use of NanoBiT and NanoBRET to monitor fluorescent VEGF-A binding kinetics to VEGFR2/NRP1 heteromeric complexes in living cells.
Peach CJ; Kilpatrick LE; Woolard J; Hill SJ
Br J Pharmacol; 2021 Jun; 178(12):2393-2411. PubMed ID: 33655497
[TBL] [Abstract][Full Text] [Related]
15. Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling.
Jin Y; Muhl L; Burmakin M; Wang Y; Duchez AC; Betsholtz C; Arthur HM; Jakobsson L
Nat Cell Biol; 2017 Jun; 19(6):639-652. PubMed ID: 28530660
[TBL] [Abstract][Full Text] [Related]
16. The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis.
Lanahan A; Zhang X; Fantin A; Zhuang Z; Rivera-Molina F; Speichinger K; Prahst C; Zhang J; Wang Y; Davis G; Toomre D; Ruhrberg C; Simons M
Dev Cell; 2013 Apr; 25(2):156-68. PubMed ID: 23639442
[TBL] [Abstract][Full Text] [Related]
17. Endoglin deficiency impairs VEGFR2 but not FGFR1 or TIE2 activation and alters VEGF-mediated cellular responses in human primary endothelial cells.
Zhang Q; Wang C; Cannavicci A; Faughnan ME; Kutryk MJB
Transl Res; 2021 Sep; 235():129-143. PubMed ID: 33894400
[TBL] [Abstract][Full Text] [Related]
18. No functional and transductional significance of specific neuropilin 1 siRNA inhibition in colon carcinoma cell lines lacking VEGF receptor 2.
Quante M; Raskopf E; Stahl S; Vogt A; Sauerbruch T; Schmitz V
Oncol Rep; 2009 May; 21(5):1161-8. PubMed ID: 19360289
[TBL] [Abstract][Full Text] [Related]
19. Real-Time Ligand Binding of Fluorescent VEGF-A Isoforms that Discriminate between VEGFR2 and NRP1 in Living Cells.
Peach CJ; Kilpatrick LE; Friedman-Ohana R; Zimmerman K; Robers MB; Wood KV; Woolard J; Hill SJ
Cell Chem Biol; 2018 Oct; 25(10):1208-1218.e5. PubMed ID: 30057299
[TBL] [Abstract][Full Text] [Related]
20. Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth.
Hamerlik P; Lathia JD; Rasmussen R; Wu Q; Bartkova J; Lee M; Moudry P; Bartek J; Fischer W; Lukas J; Rich JN; Bartek J
J Exp Med; 2012 Mar; 209(3):507-20. PubMed ID: 22393126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
